A panelist discusses how they prioritize specific clinical and laboratory parameters when assessing response to first-line therapy in patients with polycythemia vera (PV) requiring combined phlebotomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback